Stockreport

Ambrx Shareholders Approve Acquisition by Johnson & Johnson

Ambrx Biopharma, Inc.  (AMAM) 
PDF SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced that its shareholders approved a propos [Read more]